Delving into the Latest Updates on Abbott AG with Synapse

Overview

本研究的主要目的:评价阿达木单抗诱导（在第4周）及维持（在第26周）临床缓解的有效性和安全性，临床缓解的定义为在中重度活动性克罗恩病且高敏C反应蛋白升高的中国受试者，克罗恩疾病活动指数（CDAI）<150。其他目的: 评价阿达木单抗治疗对其他疗效指标的作用，包括临床应答、无类固醇缓解和生活质量的改善

[Translation]

The primary objective of this study is to evaluate the efficacy and safety of adalimumab in inducing (at week 4) and maintaining (at week 26) clinical remission, defined as a Crohn's Disease Activity Index (CDAI) <150 in Chinese subjects with moderate to severe active Crohn's disease and elevated high-sensitivity C-reactive protein. Other objectives: To evaluate the effect of adalimumab treatment on other efficacy indicators, including clinical response, steroid-free remission, and improvement in quality of life

Start Date17 Aug 2015

Sponsor / Collaborator

Abbott AG

[+2]

CTR20130986 / CompletedPhase 2

评价两组阿达木单抗剂量方案在hs-CRP升高的中重度活动性克罗恩病的中国受试者中的药代动力学、安全性和有效性

[Translation] To evaluate the pharmacokinetics, safety, and efficacy of two adalimumab dosing regimens in Chinese subjects with moderately to severely active Crohn's disease and elevated hs-CRP

本研究目的是研究用于患有克罗恩病的中国受试者的有效性、安全性和药代动力学。

[Translation]

The aim of this study was to investigate the efficacy, safety, and pharmacokinetics of levofloxacin in Chinese subjects with Crohn's disease.

Start Date23 Dec 2013

Sponsor / Collaborator

Abbott AG

[+2]

CTR20130367 / CompletedPhase 3

一项3期随机双盲安慰剂对照多中心的研究评价中国中重度斑块型银屑病受试者使用阿达木单抗的安全性和有效性

[Translation] A phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of adalimumab in Chinese subjects with moderate to severe plaque psoriasis

该研究的目的是评价中国中重度斑块型银屑病受试者使用阿达木单抗的安全性和有效性。

[Translation]

The purpose of this study is to evaluate the safety and efficacy of adalimumab in Chinese subjects with moderate to severe plaque psoriasis.

Start Date31 Jul 2012

Sponsor / Collaborator

Abbott AG

[+2]

100 Clinical Results associated with Abbott AG

Login to view more data

0 Patents (Medical) associated with Abbott AG

Login to view more data

100 Deals associated with Abbott AG

Login to view more data

100 Translational Medicine associated with Abbott AG

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data